Journals / Balkan Medical Journal / 2013 / Cilt: 30 - Sayı: 2

Neuropeptide Y gene promoter -399T/C polymorphism increases risk of ischemic stroke

Pages
147–150
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The -399T/C polymorphism of the NPY gene is associated with ischemic stroke in Han Chinese individuals, and the CC genotype may be a risk factor for ischemic stroke.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Several genetic factors underlying ischemic stroke have been identified.
📊
Key Findings & Data:Variants of Neuropeptide Y (NPY), whose product plays diverse roles in modulating physiological functions, have been associated with an increased risk of ischemic stroke in South Korean individuals.
💡
Conclusion & Impact:Conclusion: The -399T/C polymorphism of the NPY gene is associated with ischemic stroke in Han Chinese individuals, and the CC genotype may be a risk factor for ischemic stroke.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: Several genetic factors underlying ischemic stroke have been identified. Variants of Neuropeptide Y (NPY), whose product plays diverse roles in modulating physiological functions, have been associated with an increased risk of ischemic stroke in South Korean individuals. Aims: We explored the association between a polymorphism in the NPY gene promoter at position -399 and the risk of ischemic stroke in Han Chinese. Study Design: Case-control study. Methods: The polymorphism -399T/C in the promoter of NPY was analysed in 500 patients with ischemic stroke and 500 healthy individuals by amplification and sequencing of this region. Non-conditional logistic regression was used to analyse association between genotypes and the risk of ischemic stroke. Results: Genotype and allele frequencies differed significantly between the ischemic stroke and control groups (P0.05). Conclusion: The -399T/C polymorphism of the NPY gene is associated with ischemic stroke in Han Chinese individuals, and the CC genotype may be a risk factor for ischemic stroke.

🔖

Cite This Article

ZHANG, X., FU, X., WANG, D., LI, Y., ZHAO, B. (2022). Neuropeptide Y gene promoter -399T/C polymorphism increases risk of ischemic stroke. Balkan Medical Journal, Cilt: 30 - Sayı: 2, 147–150. https://ajindex.com/articles/461570

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Feigin VL. Stroke epidemiology in the developing world. Lancet 2001
  2. [CrossRef] 2. Eltzschig HK, Eckle T. Ischemia and reperfusion--from mechanism to translation. Nat Med 2011
  3. [CrossRef] 3. Rodriguez-Hernández A, Josephson AS, Langer D, Lawton MT. Bypass for the prevention of ischemic stroke. World Neurosurg 2011
  4. S72-9. [CrossRef] 4. Flossmann E, Sehulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004
  5. [CrossRef] 5. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 2003
  6. [CrossRef] 6. Meschia JF, Worrall BB, Rich SS. Genetic susceptibility to ischemic stroke. Nat Rev Neurol 2011
  7. [CrossRef] 7. Lundberg JM, Terenius L, Hökfelt T, Martling CR, Tatemoto K, Mutt V, et al. Neuropeptide Y (NPY) like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 1982
  8. [CrossRef] 8. Walker P, Grouzmann E, Burnier M, Waeber B. The role of neuropeptide Y in cardiovaseular regulation. Trends Pharmacol Sci 1991
  9. [CrossRef] 9. Erlinge D, Brunkwall J, Edvinsson L. Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP. Regul Pept 1994
  10. [CrossRef] 10. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 1998
  11. [CrossRef] 11. Renner W, Grammer T, Hoffmann MM, Nauck MS, Winkelmann BR, Boehm BO, et al. Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population. J Hypertens 2004
  12. [CrossRef] 12. Itokawa M, Arai M, Kato S, Ogata Y, Furukawa A, Haga S, et al. Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neurosei Lett 2003
  13. [CrossRef] 13. Shah SH, Freedman NJ, Zhang L, Crosslin DR, Stone DH, Haynes C, et al. Neuropeptide Y Gene polymorphisms Confer Risk of Early-Onset Atherosclerosis. PLoS Genet 2009
  14. e1000318. [CrossRef] 14. Kharlamov EA, Kharlamov A, Kelly KM. Changes in neuropeptide Y protein expression following photothrombotic brain infarction and epileptogenesis. Brain Res 2007
  15. [CrossRef] 15. Lee C